Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors.
Liu W, Xue F, Fu R, Ding B, Li M, Sun T, Chen Y, Liu X, Ju M, Dai X, Wu Q, Zhou Z, Yu J, Wang X, Zhu Q, Zhou H, Yang R, Zhang L.
Liu W, et al. Among authors: li m.
J Thromb Haemost. 2023 Jun;21(6):1453-1465. doi: 10.1016/j.jtha.2023.01.040. Epub 2023 Feb 14.
J Thromb Haemost. 2023.
PMID: 36796484
Free article.
Clinical Trial.